
agilon health, inc.: shareholders and insiders
Price
$89.50
November 19, 2026Market cap $1.5B
What Ploutos Investor adds for agilon health
Part of Ploutos Investor, €9.99 a month
- The full history: 7 fiscal years, from 2019
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.
Insiders and their shares
Purchases and sales by officers and directors from Nov 20, 2025 to Aug 18, 2026, from their own Form 4 filings.
Bought on the market
$300.0K
2 people
Sold on the market
–
nobody
From Nov 20, 2025 to Nov 20, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
No sales in the period.
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 20, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·bought $300.0K by 2 people·no sales
- 2025: no buys, no sales
- 2026: bought $300.0K by 2 people, no sales
- Aug 16, 2026Timothy GertschChief Accounting OfficerKind
- Aug 1, 2026Denise ZamoreChief Legal OfficerKind
- Jul 1, 2026Jeffrey A. SchwanekeChief Financial OfficerKind
- Jun 2, 2026John William WulfDirectorKind
- Jun 2, 2026Ronald A WilliamsDirectorKind
- Jun 2, 2026Karen McLoughlinDirectorKind
- Jun 2, 2026Diana MckenzieDirectorKind
- Jun 2, 2026Sharad MansukaniDirectorKind
- Jun 2, 2026Silvana BattagliaDirectorKind
- Jun 1, 2026Denise ZamoreChief Legal OfficerKind
- May 24, 2026Timothy GertschChief Accounting OfficerKind
- Mar 9, 2026Benjamin ShakerChief Markets OfficerKind
- Mar 9, 2026Denise ZamoreChief Legal OfficerKind
- Mar 2, 2026Benjamin ShakerChief Markets OfficerKind
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 16, 2026 | Timothy GertschChief Accounting Officer | 17 | $96.90 | $1.6K | Form 4 | |
| Aug 1, 2026 | Denise ZamoreChief Legal Officer | 37 | $91.61 | $3.4K | Form 4 | |
| Jul 1, 2026 | Jeffrey A. SchwanekeChief Financial Officer | 2,311 | $111.74 | $258.2K | Form 4 | |
| Jun 2, 2026 | John William WulfDirector | 2,133 | – | – | Form 4 | |
| Jun 2, 2026 | Ronald A WilliamsDirector | 2,133 | – | – | Form 4 | |
| Jun 2, 2026 | Karen McLoughlinDirector | 2,133 | – | – | Form 4 | |
| Jun 2, 2026 | Diana MckenzieDirector | 2,133 | – | – | Form 4 | |
| Jun 2, 2026 | Sharad MansukaniDirector | 2,133 | – | – | Form 4 | |
| Jun 2, 2026 | Silvana BattagliaDirector | 2,133 | – | – | Form 4 | |
| Jun 1, 2026 | Denise ZamoreChief Legal Officer | 485 | $92.54 | $44.9K | Form 4 | |
| May 24, 2026 | Timothy GertschChief Accounting Officer | 8 | $86.39 | $691 | Form 4 | |
| Mar 9, 2026 | Benjamin ShakerChief Markets Officer | 18.4K | – | – | Form 4 | |
| Mar 9, 2026 | Denise ZamoreChief Legal Officer | 5,535 | – | – | Form 4 | |
| Mar 2, 2026 | Benjamin ShakerChief Markets Officer | 500.0K | $0.60 | $300.0K | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before May 27, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by AGL's officers and directors from 2021 up to November 19, 2025, 5 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- Morgan Stanleywith 1 more personShare of class12.2%
- North Peak Capital Management, LLCwith 7 more personsShare of class9.50%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Morgan Stanleywith 1 more person | 12.2% | 50.20M | May 5, 2025 | 13G/A | |
| North Peak Capital Management, LLCwith 7 more persons | 9.50% | 39.41M | Nov 13, 20252 filings since Aug 29, 2025 | 13G/A |
Fell to 5% or less (7)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
- AQR Capital Management, LLC4.15%Aug 12, 202613G/A
- The Goldman Sachs Group3.90%Aug 11, 202613G/A
- The Vanguard Group4.41%Jan 30, 202613G/A
- FMR3.70%Nov 5, 202513G/A
- Capital World Investors2.60%Sep 5, 202513G/A
- Capital International Investors2.40%Aug 13, 202513G/A
- Wellington Management Group LLP3.60%May 12, 202513G/A
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Renaissance TechnologiesIn the quarter+72%
- AQR CapitalIn the quarter-2.0%
- Point72 (Cohen)In the quarter+86%
- D.E. ShawIn the quarter-53%
- Citadel Advisors (Griffin)In the quarter+56%
- Millennium Mgmt (Englander)In the quarter-70%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Renaissance Technologies | 262.2K | +72% | $21M | 0.03% |
| AQR Capital | 678.4K | -2.0% | $54M | 0.02% |
| Point72 (Cohen) | 60.7K | +86% | $4.8M | 0.01% |
| D.E. Shaw | 183.5K | -53% | $15M | 0.01% |
| Citadel Advisors (Griffin) | 87.3K | +56% | $6.9M | 0.00% |
| Millennium Mgmt (Englander) | 10.1K | -70% | $800.0K | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 5.42% of its shares outstanding were held short, -10.9% since the report before.
- Shares held short
- 899.1K
- 5.42%
- Since the report before1.01M on Sep 30, 2026
- -10.9%
- 4.6
- 197.2K
- More days to cover thanof 4,578 US-listed companies with enough volume
- 55%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 46.38M
- Nov 15, 2023: Shares held short 49.33M
- Nov 30, 2023: Shares held short 48.98M
- Dec 15, 2023: Shares held short 47.09M
- Dec 29, 2023: Shares held short 45.59M
- Jan 12, 2024: Shares held short 47.49M
- Jan 31, 2024: Shares held short 44.75M
- Feb 15, 2024: Shares held short 46.12M
- Feb 29, 2024: Shares held short 47.97M
- Mar 15, 2024: Shares held short 46.96M
- Mar 28, 2024: Shares held short 47.02M
- Apr 15, 2024: Shares held short 46.02M
- Apr 30, 2024: Shares held short 44.28M
- May 15, 2024: Shares held short 44.66M
- May 31, 2024: Shares held short 43.89M
- Jun 14, 2024: Shares held short 43.62M
- Jun 28, 2024: Shares held short 43.31M
- Jul 15, 2024: Shares held short 45.86M
- Jul 31, 2024: Shares held short 44.14M
- Aug 15, 2024: Shares held short 38.70M
- Aug 30, 2024: Shares held short 41.15M
- Sep 13, 2024: Shares held short 39.42M
- Sep 30, 2024: Shares held short 36.49M
- Oct 15, 2024: Shares held short 35.88M
- Oct 31, 2024: Shares held short 36.22M
- Nov 15, 2024: Shares held short 30.39M
- Nov 29, 2024: Shares held short 31.94M
- Dec 13, 2024: Shares held short 29.79M
- Dec 31, 2024: Shares held short 27.76M
- Jan 15, 2025: Shares held short 25.25M
- Jan 31, 2025: Shares held short 20.24M
- Feb 14, 2025: Shares held short 18.50M
- Feb 28, 2025: Shares held short 16.82M
- Mar 14, 2025: Shares held short 18.56M
- Mar 31, 2025: Shares held short 18.27M
- Apr 15, 2025: Shares held short 19.13M
- Apr 30, 2025: Shares held short 21.96M
- May 15, 2025: Shares held short 22.20M
- May 30, 2025: Shares held short 20.07M
- Jun 13, 2025: Shares held short 21.23M
- Jun 30, 2025: Shares held short 20.84M
- Jul 15, 2025: Shares held short 17.82M
- Jul 31, 2025: Shares held short 18.92M
- Aug 15, 2025: Shares held short 19.11M
- Aug 29, 2025: Shares held short 18.17M
- Sep 15, 2025: Shares held short 22.79M
- Sep 30, 2025: Shares held short 19.79M
- Oct 15, 2025: Shares held short 20.40M
- Oct 31, 2025: Shares held short 20.88M
- Nov 14, 2025: Shares held short 20.80M
- Nov 28, 2025: Shares held short 17.93M
- Dec 15, 2025: Shares held short 20.64M
- Dec 31, 2025: Shares held short 19.39M
- Jan 15, 2026: Shares held short 20.41M
- Jan 30, 2026: Shares held short 20.18M
- Feb 13, 2026: Shares held short 20.41M
- Feb 27, 2026: Shares held short 24.59M
- Mar 13, 2026: Shares held short 26.65M
- Mar 31, 2026: Shares held short 1.36M
- Apr 15, 2026: Shares held short 1.00M
- Apr 30, 2026: Shares held short 791.5K
- May 15, 2026: Shares held short 639.7K
- May 29, 2026: Shares held short 632.2K
- Jun 15, 2026: Shares held short 647.4K
- Jun 30, 2026: Shares held short 723.2K
- Jul 15, 2026: Shares held short 859.4K
- Jul 31, 2026: Shares held short 872.2K
- Aug 14, 2026: Shares held short 978.8K
- Aug 31, 2026: Shares held short 1.08M
- Sep 15, 2026: Shares held short 1.05M
- Sep 30, 2026: Shares held short 1.01M
- Oct 15, 2026: Shares held short 899.1K
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading59.5% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 59.5% of the shares in the reported trades were short sales, against 62.2% in the 14 before.
- Last 14 sessionsNov 2, 2026 – Nov 19, 2026
- 59.5%
- The 14 beforeOct 13, 2026 – Oct 30, 2026
- 62.2%
- Change
- -2.7 pts
- Short sales a dayon average, of 120.9K shares
- 71.9K
- More than atof 3,666 US-listed companies, same days
- 81%
- Median of alleight in ten from 34.5% to 63.8%
- 50.4%
- Short sales
- Oct 13, 2026: Short sales 68.7%
- Oct 14, 2026: Short sales 65%
- Oct 15, 2026: Short sales 70.5%
- Oct 16, 2026: Short sales 60%
- Oct 19, 2026: Short sales 70.1%
- Oct 20, 2026: Short sales 58.6%
- Oct 21, 2026: Short sales 59.9%
- Oct 22, 2026: Short sales 55.9%
- Oct 23, 2026: Short sales 68.4%
- Oct 26, 2026: Short sales 73.1%
- Oct 27, 2026: Short sales 58.1%
- Oct 28, 2026: Short sales 45.7%
- Oct 29, 2026: Short sales 64.2%
- Oct 30, 2026: Short sales 58.7%
- Nov 2, 2026: Short sales 59.7%
- Nov 3, 2026: Short sales 62.4%
- Nov 4, 2026: Short sales 55.2%
- Nov 5, 2026: Short sales 56.6%
- Nov 6, 2026: Short sales 53.7%
- Nov 9, 2026: Short sales 61.6%
- Nov 10, 2026: Short sales 56.3%
- Nov 11, 2026: Short sales 53.9%
- Nov 12, 2026: Short sales 67.8%
- Nov 13, 2026: Short sales 52.3%
- Nov 16, 2026: Short sales 55.9%
- Nov 17, 2026: Short sales 61.1%
- Nov 18, 2026: Short sales 65.4%
- Nov 19, 2026: Short sales 60.7%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Benjamin ShakerChief Markets OfficerDirectly1.39M
- Steven SellCEO & PresidentDirectly370.9K
- Veeral DesaiChief Strategy & Dev. OfficerDirectly311.5K
- Girish VenkatachaliahChief Technology OfficerDirectly285.1K
- Ronald A WilliamsDirectorDirectly149.1K
- Jeffrey A. SchwanekeChief Financial OfficerDirectly115.7K
- Denise ZamoreChief Legal OfficerDirectly66.1K
- Benjamin KornitzerChief Med. & Quality OfficerDirectly63.9K
- Sharad MansukaniDirectorDirectly56.2K
- Timothy BensleyChief Financial OfficerDirectly50.1K
- John William WulfDirectorDirectly16.8K
- Timothy GertschChief Accounting OfficerDirectly14.2K
- Karen McLoughlinDirectorDirectly8,207
- Silvana BattagliaDirectorDirectly7,926
- Diana MckenzieDirectorDirectly7,633
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Benjamin ShakerChief Markets Officer | 1.39M | – | Mar 9, 2026 | Form 4 |
| Steven SellCEO & President | 370.9K | 67.6K | Mar 14, 2025 | Form 4 |
| Veeral DesaiChief Strategy & Dev. Officer | 311.5K | – | Mar 14, 2024 | Form 4 |
| Girish VenkatachaliahChief Technology Officer | 285.1K | – | Mar 9, 2026 | Form 4 |
| Ronald A WilliamsDirector | 149.1K | – | Jun 2, 2026 | Form 4 |
| Jeffrey A. SchwanekeChief Financial Officer | 115.7K | 22.3K | Jul 1, 2026 | Form 4 |
| Denise ZamoreChief Legal Officer | 66.1K | – | Aug 1, 2026 | Form 4 |
| Benjamin KornitzerChief Med. & Quality Officer | 63.9K | – | Mar 14, 2024 | Form 4 |
| Sharad MansukaniDirector | 56.2K | – | Jun 2, 2026 | Form 4 |
| Timothy BensleyChief Financial Officer | 50.1K | – | Mar 14, 2024 | Form 4 |
| John William WulfDirector | 16.8K | – | Jun 2, 2026 | Form 4 |
| Timothy GertschChief Accounting Officer | 14.2K | – | Aug 16, 2026 | Form 4 |
| Karen McLoughlinDirector | 8,207 | – | Jun 2, 2026 | Form 4 |
| Silvana BattagliaDirector | 7,926 | – | Jun 2, 2026 | Form 4 |
| Diana MckenzieDirector | 7,633 | – | Jun 2, 2026 | Form 4 |
A lower bound: it counts only the 15 officers and directors with a market trade since Nov 21, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- IHFiShares U.S. Healthcare Providers ETFWeight in the fund0.20%
- FNDASchwab Fundamental U.S. Small Company ETFWeight in the fund0.19%
- IWOiShares Russell 2000 Growth ETFWeight in the fund0.08%
- IWMiShares Russell 2000 ETFWeight in the fund0.04%
- VTWOVanguard Russell 2000 Index FundWeight in the fund0.04%
- SCHASchwab U.S. Small-Cap ETFWeight in the fund0.02%
- VXFVanguard Extended Market Index FundWeight in the fund0.02%
- VHTVanguard Health Care Index FundWeight in the fund0.01%
- ITOTiShares Core S&P Total U.S. Stock Market ETFWeight in the fund0.00%
- IWViShares Russell 3000 ETFWeight in the fund0.00%
13 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 192
- Q4 2025: Managers 197
- Q1 2026: Managers 99
- Q2 2026: Managers 179
Institutional investors by quarter
The fund managers holding AGL, quarter by quarter, from Q2 2021 to Q2 2025, 17 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 179 managers held 16.19M shares, worth $1.7B. During the quarter 94 opened a position, 14 closed one, 34 added and 34 trimmed.
The largest holders, Q2 2026
- Clayton, Dubilier & RiceIn the quarter
- Morgan StanleyIn the quarter-4.2%
- North Peak Capital ManagementIn the quarter-3.9%
- BlackRockIn the quarter+31%
- AQR CapitalIn the quarter-29%
- Goldman Sachs GroupIn the quarter-35%
- Vanguard Capital ManagementIn the quarter-2.5%
- Marshall WaceIn the quarter
- Durable Capital PartnersIn the quarter
- D.E. ShawIn the quarter-47%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| Clayton, Dubilier & Rice | 4.00M | $429M | |
| Morgan Stanley | 2.01M | -4.2% | $216M |
| North Peak Capital Management | 1.49M | -3.9% | $159M |
| BlackRock | 1.15M | +31% | $123M |
| AQR Capital | 692.5K | -29% | $74M |
| Goldman Sachs Group | 686.8K | -35% | $74M |
| Vanguard Capital Management | 525.3K | -2.5% | $56M |
| Marshall Wace | 468.3K | $50M | |
| Durable Capital Partners | 440.6K | $47M | |
| D.E. Shaw | 390.1K | -47% | $42M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do agilon health's filings show?
Who buys and sells is one part of agilon health's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have AGL's insiders bought or sold?
From May 27, 2026 to Aug 18, 2026 agilon health's insiders reported no purchase or sale of shares on the market.
Which well-known managers hold AGL?
6 of the managers we track held the shares on Sep 30, 2026. The largest position was AQR Capital's, worth $54M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.